Metaphore Pharmaceuticals Inc. is a privately held emerging pharmaceutical company with offices in Fort Lee, New Jersey and St. Louis, MO. The company leverages its expertise to discover and develop small molecule compounds that mimic the function of superoxide dismutase, a beneficial enzyme that serves an important protective role in the body by removing superoxide, a toxic free radical that can damage cells and tissues. Superoxide anions are implicated in a wide variety of diseases associated with pain and inflammation. Metaphore currently focuses its clinical development efforts in pain, arthritis and inflammatory disorders which represent significant markets in terms of scope and size.
View Top Employees from Metaphore Pharmaceuticals , Inc.| Website | http://www.metaphore.com |
| Revenue | $9.4 million |
| Employees | View employees |
| Founded | 1998 |
| Address | Gasstraße 10, Hamburg, Hamburg 22761, DE |
| Phone | +49 40 460037500 |
| Fax | (314) 426-7491 |
| Industry | Pharmaceuticals, Drug Discovery, Healthcare, Biotechnology, Drug Manufacturing & Research |
| SIC | SIC Code 28 Companies, SIC Code 2834 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 3254 Companies |
Looking for a particular Metaphore Pharmaceuticals , Inc. employee's phone or email?
Metaphore Pharmaceuticals , Inc. Questions
The Metaphore Pharmaceuticals , Inc. annual revenue was $9.4 million in 2023.
Metaphore Pharmaceuticals , Inc. is based in Hamburg, Hamburg.
The NAICS codes for Metaphore Pharmaceuticals , Inc. are [32, 32541, 325, 3254].
The SIC codes for Metaphore Pharmaceuticals , Inc. are [28, 2834, 283].
